Article ; Online: Human Induced Pluripotent Stem Cell-Derived Lung Epithelial System for SARS-CoV-2 Infection Modeling and Its Potential in Drug Repurposing.
2020 Volume 29, Issue 21, Page(s) 1365–1369
Abstract: The lung is the most vulnerable target for the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, and respiratory failure causing acute respiratory distress syndrome is its foremost outcome. However, the current primary in vitro ... ...
Abstract | The lung is the most vulnerable target for the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, and respiratory failure causing acute respiratory distress syndrome is its foremost outcome. However, the current primary in vitro models in use for SARS-CoV-2 display apparent limitations for modeling such complex human respiratory disease. Although patient cells can directly model the effects of a drug, their availability and capacity for expansion are limited compared with transformed/immortalized cells or tumor-derived cell lines. An additional caveat is that the latter may harbor genetic and metabolic abnormalities making them unsuitable for drug screening. Therefore, it is important to create physiologically relevant human-cell models that can replicate the pathophysiology of SARS-CoV-2, thus facilitating drug testing. In this study, we show preliminary data on how human induced pluripotent stem cells-derived lung epithelial cell system could emerge as a relevant and sensitive platform for modeling SARS-CoV-2 infection and drug screening. |
---|---|
MeSH term(s) | COVID-19/drug therapy ; COVID-19/pathology ; Cell Line ; Drug Evaluation, Preclinical/methods ; Drug Repositioning ; Humans ; Induced Pluripotent Stem Cells/virology ; Lung/cytology ; Models, Biological ; Respiratory Distress Syndrome/pathology ; Respiratory Distress Syndrome/prevention & control ; SARS-CoV-2/drug effects |
Keywords | covid19 |
Language | English |
Publishing date | 2020-09-18 |
Publishing country | United States |
Document type | Letter ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2142214-X |
ISSN | 1557-8534 ; 1547-3287 |
ISSN (online) | 1557-8534 |
ISSN | 1547-3287 |
DOI | 10.1089/scd.2020.0152 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 3616: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.